Trials / Completed
CompletedNCT05060874
Gripwise® Versus JAMAR®
Comparison of Gripstrength Assessment Between the Gripwise® and JAMAR® Dynamometers in Elderly Inpatients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 348 (actual)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.
Conditions
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2021-09-01
- Completion
- 2021-11-18
- First posted
- 2021-09-29
- Last updated
- 2021-11-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05060874. Inclusion in this directory is not an endorsement.